Top Tweets for #Talapro2
Impact of baseline demographics on therapy management in patients with #mCRPC treated with talazoparib + enzalutamide in the #TALAPRO2 study: Extended follow-up. Presentation by @UgoDeGiorgi @IstTumori. #ASCO26 written coverage by @RKSayyid @UAUrology > https://t.co/myKEcOxHH9 @ASCO
Radiographic PFS as a meaningful endpoint in #mCRPC: The #TALAPRO2 randomized clinical trial. Presented by @neerajaiims @huntsmancancer. #AUA26 written coverage by @zklaassen_md > https://t.co/f5JQOuC3Y8 @AmerUrological
#TALAPRO2: First patient-level rPFS–OS correlation analysis for a PARP inhibitor in first-line #mCRPC — and results held across unselected, HRR-deficient, and BRCAm subgroups.
Spearman ρ ranged from 0.649–0.842 across cohorts and treatment arms.
@AmerUrological #AUA26 @neerajaiims @huntsmancancer #pcsm
Learn more 👉: https://t.co/Tz64ij1lDh
Overall survival results from the #TALAPRO2 trial in #mCRPC patients. @neerajaiims @huntsmancancer joins Oliver Sartor, MD @EJHospital to discuss the OS results from the TALAPRO-2 trial, which led to approval of talazoparib + enzalutamide for metastatic castration-resistant #ProstateCancer. #WatchNow > https://t.co/Z5yvoXktjw
Overall survival results from the #TALAPRO2 trial in #mCRPC patients. @neerajaiims @huntsmancancer joins Oliver Sartor, MD @EJHospital to discuss the OS results from the TALAPRO-2 trial, which led to approval of talazoparib + enzalutamide for metastatic castration-resistant #ProstateCancer. #WatchNow > https://t.co/Z5yvoXktjw
Overall survival results from the #TALAPRO2 trial in #mCRPC patients. @neerajaiims @huntsmancancer joins Oliver Sartor, MD @EJHospital to discuss the OS results from the TALAPRO-2 trial, which led to approval of talazoparib + enzalutamide for metastatic castration-resistant #ProstateCancer. #WatchNow > https://t.co/Z5yvoXktjw
Overall survival results from the #TALAPRO2 trial in #mCRPC patients. @neerajaiims @huntsmancancer joins Oliver Sartor, MD @EJHospital to discuss the OS results from the TALAPRO-2 trial, which led to approval of talazoparib + enzalutamide for metastatic castration-resistant #ProstateCancer. #WatchNow > https://t.co/Z5yvoXktjw
Talazoparib-enzalutamide combination and quality of life in #mCRPC patients. Nobuaki Matsubara, MD joins @neerajaiims @huntsmancancer to discuss final patient-reported outcomes data from the #TALAPRO2 trial. #WatchNow on UroToday > https://t.co/PMAqNuoH8I
Overall survival results from the #TALAPRO2 trial in #mCRPC patients. @neerajaiims @huntsmancancer joins Oliver Sartor, MD @EJHospital to discuss the OS results from the TALAPRO-2 trial, which led to approval of talazoparib + enzalutamide for metastatic castration-resistant #ProstateCancer. #WatchNow > https://t.co/Z5yvoXktjw
Talazoparib-enzalutamide combination and quality of life in #mCRPC patients. Nobuaki Matsubara, MD joins @neerajaiims @huntsmancancer to discuss final patient-reported outcomes data from the #TALAPRO2 trial. #WatchNow on UroToday > https://t.co/PMAqNuoH8I
Overall survival results from the #TALAPRO2 trial in #mCRPC patients. @neerajaiims @huntsmancancer joins Oliver Sartor, MD @EJHospital to discuss the OS results from the TALAPRO-2 trial, which led to approval of talazoparib + enzalutamide for metastatic castration-resistant #ProstateCancer. #WatchNow > https://t.co/Z5yvoXktjw
Talazoparib-enzalutamide combination and quality of life in #mCRPC patients. Nobuaki Matsubara, MD joins @neerajaiims @huntsmancancer to discuss final patient-reported outcomes data from the #TALAPRO2 trial. #WatchNow on UroToday > https://t.co/PMAqNuoH8I
Talazoparib and enzalutamide in unselected #mCRPC patients. @neerajaiims @huntsmancancer joins Oliver Sartor, MD @MayoClinic to discuss updated #TALAPRO2 results exploring talazoparib + enzalutamide in metastatic castration-resistant #ProstateCancer. #WatchNow > https://t.co/kWF1VuK12j
🚨 This week on the OncoAlert RoundUp!
🎯 Unmissable updates from July 11–17 🔥
➡️ #TALAPRO2 in 🔵 #ProstateCancer
➡️ Geriatric 👴 Assessment in Oncology
➡️ Molecular insights in 🟢 #KidneyCancer (non-ccRCC)
➡️ #POSITIVETrial in 🎗 #BreastCancer
➡️ Mutational forces in 🫁 #LungCancer
➡️ ACCORD trial in 🟠 #BladderCancer
➡️ dMMR 🧬 targeting strategies
➡️ Gut Microbiome & Cancer 🦠 @ReginaBarCar
… and more!
📲 Register 👉 https://t.co/kHfE8oDWmE
#OncoAlert #Oncology #CancerResearch #MedTwitter
The OncoAlert WEEKLY RoundUp 🚨
Covering the TOP of the week July 11-17, 2025
👉REGISTER at https://t.co/QFM2SYXqbg OR https://t.co/hwvqbilbLO
Discussing:
✅TALAPRO2 in #ProstateCancer
✅Geriatric Assessment 👴
✅Molecular Landscape of Non Clear Cell Renal Carcinoma #KidneyCancer
✅POSITIVE Trial in #BreastCancer
✅mutagenic forces shaping Genomes in #LungCancer
✅ACCORD in Cholangiocarcinoma #BladderCancer
✅Therapeutic targeting of mismatch repair-deficient cancer
✅Microbiome Modulation for the Treatment of Solid Neoplasms @ReginaBarCar
.......And much more
@CACancerJournal @neerajaiims @montypal @VivekSubbiah @dogranavneet @MehrazinMD @DrYukselUrun @AnisToumeh @medoncodoc @matteolambe @Icro_Meattini @JournalCancer @Tony_Calles @g_mountzios @TejasPatilMD @Aiims1742 @Cancer_Cell @dr_yakupergun @shilpaonc @ZeynepZengin @HerediaOncologo @DraMartinezLago @GillSharlene @Amolpatel_dr @PGrivasMDPhD @crisbergerot @amerseburger @cdanicas @drenriquegrande
#OncoAlertAF
@nataliagandur @acampsmalea @BRicciutiMD
@yekeduz_emre @HHorinouchi @FadiHaddad_MD
@Abdallah81MD @FernandoOnco
@ElisaAgostinett @to_be_elizabeth @bavilima @realbowtiedoc @Erman_Akkus @Lucarecco @GaiaGriguolo @JankovicK
@MarioBalsaMD @DrMirallas @GIMedOnc @OscarTahuahua
An amazing contribution to the field. Congrats to the #TALAPRO2 team, led by @neerajaiims @huntsmancancer! Two simultaneous publications in @TheLancet to reflect this practice changing dataset!
Just came online in @TheLancet 👉Our two papers on improved OS with Enzalutamide + Talazoparib in mCRPC #ProstateCancer in all-comer & HRRm patients (Median OS and HRs👇). Weblinks to the papers👉 https://t.co/AMqlUvlkNG and https://t.co/W8gO8lWxQo @PCFnews @urotoday @OncoAlert
Talazoparib and enzalutamide in unselected #mCRPC patients. @neerajaiims @huntsmancancer joins Oliver Sartor, MD @MayoClinic to discuss updated #TALAPRO2 results exploring talazoparib + enzalutamide in metastatic castration-resistant #ProstateCancer. #WatchNow > https://t.co/kWF1VuK12j
Talazoparib improves survival in HRR-mutated #mCRPC patients in #TALAPRO2 trial. Karim Fizazi, MD @GustaveRoussy sits down with @CaPsurvivorship @DanaFarber to discuss updated OS data from #TALAPRO2: Talazoparib + enzalutamide cuts death risk by 40% (HR 0.6) in mCRPC with HRR mutations. 🧬 BRCA+ patients see the biggest gains, with median OS not yet reached! 💪 Early PARP inhibitor use is key. #WatchNow on UroToday > https://t.co/y0IxTA2L2j
Talazoparib and enzalutamide in unselected #mCRPC patients. @neerajaiims @huntsmancancer joins Oliver Sartor, MD @MayoClinic to discuss updated #TALAPRO2 results exploring talazoparib + enzalutamide in metastatic castration-resistant #ProstateCancer. #WatchNow > https://t.co/kWF1VuK12j
Exploratory analyses of HRR alterations by gene subgroup and potential associations with efficacy in the HRR-deficient population from #TALAPRO2. Presentation by Stefanie Zschaebitz, MD. #ASCO25 written coverage by @zklaassen_md @GACancerCenter > https://t.co/iUnWkAElYX @ASCO
Last Seen Hashtags on Sotwe
Babecock
Seen from Canada
homemade
Seen from Pakistan
trans
Seen from United States
istanbuleskort
Seen from Turkey
gachaporn video
Seen from Malaysia
AtmosCollectorsClub
Seen from United States
femboy
Seen from United Arab Emirates
minichat
momsonn((()))*******
Seen from Mexico
deadtoons nsfw
Seen from Canada
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.7M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers